1. Gasotransmitters in vascular complications of diabetes;van den Born;Diabetes
2. The current drug treatment landscape for diabetes and perspectives for the future;Bailey;Clin Pharmacol Ther,2015
3. Evans JL, Balkan B, Rushakoff RJ. Oral and injectable (non-insulin) pharmacological agents for type 2 diabetes. In Endotext: Diabetes Mellitus and Carbohydrate Metabolism—DiabetesManager. 1st ed. De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, Eds. South Dartmouth, MA, MDText.com, 2015. Available from http://www.endotext.org/section/diabetes/. Accessed 27 November 2015
4. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes;Evans;Endocr Rev,2002